ArticleAnimal models and experimental medicine2026
Repeated instillations of bleomycin in male mice induce a perivascular remodeling at distance of fibrotic areas in the context of progressive pulmonary fibrosis.
Article in Animal models and experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Repeated instillations of bleomycin in male mice induce a perivascular remodeling at distance of fibrotic areas in the context of progressive pulmonary fibrosis.Animal models and experimental medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Idiopathic pulmonary fibrosis (IPF) is the archetypal form of progressive pulmonary fibrosis (PPF), as well as being the most common and severe type of interstitial lung disease. IPF is characterized by progressive, diffuse interstitial remodeling, stiffening of the lung parenchyma and is also most often associated with pulmonary hypertension (PH), which significantly impacts the clinical course and outcome of the disease. To improve targeted therapeutic options and survival predictions, as well as offering an overall better understanding of the disease, researchers need models that best reflect the characteristics observed in patients and allow the study of comorbidities associated with pulmonary fibrosis. Chronic pulmonary fibrosis was induced in male C57BL/6 mice through intratracheal instillation (ITI) of 3 low-doses of bleomycin (BLM) every 2 weeks. Mice were sacrificed 15 or 90 days after the last ITI. Clinical follow-up and histological analysis were performed to study lung and perivascular remodeling. Our results suggest that fractionated bleomycin instillation generates a persistent and progressive pulmonary fibrosis in mice. This is associated with collagen remodeling in the perivascular space outside fibrotic areas. We hypothesize that this remodeling, accompanied by a mild but significant increase in pulmonary artery media thickness, could be a precursor to pulmonary fibrosis-associated hypertension. These results suggest that this model could improve our understanding of pulmonary remodeling and vascular lesions in the early stages of pulmonary fibrosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.